Oxidative Stress in Alzheimer Disease: Synergy Between the Butterfield and Markesbery Laboratories

Aksenov M.Y., Aksenova M.V., Butterfield D.A., Geddes J.W., Markesbery W.R., Protein oxidation in the brain in Alzheimer's disease, Neuroscience, 103, 2, pp. 373-383, (2001)

Aksenov M., Aksenova M., Butterfield D.A., Markesbery W.R., Oxidative modification of creatine kinase BB in Alzheimer's disease brain, Journal of Neurochemistry, 74, 6, pp. 2520-2527, (2000)

Boyd-Kimball D., Abdul H.M., Reed T., Sultana R., Butterfield D.A., Role of phenylalanine 20 in Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity, Chemical Research in Toxicology, 17, 12, pp. 1743-1749, (2004)

Boyd-Kimball D., Poon H.F., Lynn B.C., Cai J., Pierce Jr. W.M., Klein J.B., Ferguson J., Link C.D., Butterfield D.A., Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Aβ(1-42): Implications for Alzheimer's disease, Neurobiology of Aging, 27, 9, pp. 1239-1249, (2006)

Boyd-Kimball D., Sultana R., Fai Poon H., Lynn B.C., Casamenti F., Pepeu G., Klein J.B., Butterfield D.A., Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1-42) into rat brain: Implications for Alzheimer's disease, Neuroscience, 132, 2, pp. 313-324, (2005)

Butterfield D.A., Proteomics: A new approach to investigate oxidative stress in Alzheimer's disease brain, Brain Research, 1000, 1-2, pp. 1-7, (2004)

Butterfield D.A., Boyd-Kimball D., Castegna A., Proteomics in Alzheimer's disease: Insights into potential mechanisms of neurodegeneration, Journal of Neurochemistry, 86, 6, pp. 1313-1327, (2003)

Allan Butterfield D., Castegna A., Lauderback C.M., Drake J., Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death, Neurobiology of Aging, 23, 5, pp. 655-664, (2002)

Butterfield D.A., Drake J., Pocernich C., Castegna A., Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid β-peptide, Trends in Molecular Medicine, 7, 12, pp. 548-554, (2001)

Butterfield D.A., Galvan V., Bader Lange M., Tang H., Sowell R.A., Spilman P., Fombonne J., Gorostiza O., Zhang J., Sultana R., Bredesen D.E., In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP, Free Radical Biology and Medicine, 48, pp. 136-144, (2010)

Aksenov M.Y., Aksenova M.V., Butterfield D.A., Geddes J.W., Markesbery W.R., Protein oxidation in the brain in Alzheimer's disease, Neuroscience, 103, 2, pp. 373-383, (2001)

Aksenov M., Aksenova M., Butterfield D.A., Markesbery W.R., Oxidative modification of creatine kinase BB in Alzheimer's disease brain, Journal of Neurochemistry, 74, 6, pp. 2520-2527, (2000)

Boyd-Kimball D., Abdul H.M., Reed T., Sultana R., Butterfield D.A., Role of phenylalanine 20 in Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity, Chemical Research in Toxicology, 17, 12, pp. 1743-1749, (2004)

Boyd-Kimball D., Poon H.F., Lynn B.C., Cai J., Pierce Jr. W.M., Klein J.B., Ferguson J., Link C.D., Butterfield D.A., Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Aβ(1-42): Implications for Alzheimer's disease, Neurobiology of Aging, 27, 9, pp. 1239-1249, (2006)

Boyd-Kimball D., Sultana R., Fai Poon H., Lynn B.C., Casamenti F., Pepeu G., Klein J.B., Butterfield D.A., Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1-42) into rat brain: Implications for Alzheimer's disease, Neuroscience, 132, 2, pp. 313-324, (2005)

Butterfield D.A., Proteomics: A new approach to investigate oxidative stress in Alzheimer's disease brain, Brain Research, 1000, 1-2, pp. 1-7, (2004)

Butterfield D.A., Boyd-Kimball D., Castegna A., Proteomics in Alzheimer's disease: Insights into potential mechanisms of neurodegeneration, Journal of Neurochemistry, 86, 6, pp. 1313-1327, (2003)

Allan Butterfield D., Castegna A., Lauderback C.M., Drake J., Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death, Neurobiology of Aging, 23, 5, pp. 655-664, (2002)

Butterfield D.A., Drake J., Pocernich C., Castegna A., Evidence of oxidative damage in Alzheimer's disease brain: Central role for amyloid β-peptide, Trends in Molecular Medicine, 7, 12, pp. 548-554, (2001)

Butterfield D.A., Galvan V., Bader Lange M., Tang H., Sowell R.A., Spilman P., Fombonne J., Gorostiza O., Zhang J., Sultana R., Bredesen D.E., In vivo oxidative stress in brain of Alzheimer disease transgenic mice: Requirement for methionine 35 in amyloid β-peptide of APP, Free Radical Biology and Medicine, 48, pp. 136-144, (2010)